This contract is to advance the development of a second-generation, multi-analyte molecular sars-COV-2 and influenza a/B test that has a reduced time to result and increased sensitivity that can be…

Ended Definitive Contract Awarded Last action

Contract number
75A50122C00010
Awardee
Awarding agency
Obligated
$25,499,669

Award facts

Opportunity
Contract value 73% obligated
  • $25,499,669.00 Current, with exercised options
  • $34,714,763.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Guilford, CT 06437, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00007 · No cost period of performance extension for clin 0001 and clin 0004, through 30 may 2025, 2. Revise section B supplies or services and prices/costs, and 3.… $0
Other Administrative Action P00006 $2,600,871
Other Administrative Action P00005 · Administrative modification to revise section F, section G, section H and the contract statement of work. $0
Other Administrative Action P00004 · Administrative modification to revise section B, section H and section I of the contract and statement of work. $0
Other Administrative Action P00003 · Bilateral agreement to revise contract and statement of work. $0
Other Administrative Action P00002 · Detect - revise contract writing system buyer for IPP invoicing. $0
Other Administrative Action P00001 · This modification is to enable the contractor to register for the new IPP (invoice processing platform) $0
Original award $22,898,798

About this award

Written by GovTribe AI ·

This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research and Development Authority (BARDA) seeking proposals to develop medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats, including vaccines, therapeutics, and diagnostics. The contract has an ultimate completion date of October 26, 2026.

Description

As the agency reported it.

This contract is to advance the development of a second-generation, multi-analyte molecular sars-COV-2 and influenza a/B test that has a reduced time to result and increased sensitivity that can be used at home or a POC setting

Quick answers

Who was awarded contract 75A50122C00010?

75A50122C00010 was awarded to Detect Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on January 24, 2022.

How much is contract 75A50122C00010 worth?

The government has obligated $25,499,669 on 75A50122C00010. Its potential value, with all options, is $34,714,763.

Was contract 75A50122C00010 competed?

The extent of competition for 75A50122C00010 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login